CTOs on the Move

Iota Biosciences

www.iota.bio

 
Established in 2017, iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning `neural-dust` technology invented at the University of California, Berkeley, we are building a platform for the future of bioelectronic medicine.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.iota.bio
  • 1936 University Ave
    Berkeley, CA USA
  • Phone: 888.666.O576

Executives

Name Title Contact Details

Funding

Iota Biosciences raised $15M on 12/27/2018

Similar Companies

SurePoint Medical

SurePoint Medical is a Lawrence, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chartwell Pennsylvania

Chartwell Pennsylvania is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Savoy Medical Supply Co Inc

Savoy Medical Supply Co Inc is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Augmedics

Augmedics develops xvision™ – an Augmented-Reality Head-Mounted Display for spine surgery. xvision allows surgeons to see the patient`s anatomy through skin and tissue, as if they had "X-Ray Vision"​. Based on Augmedics` patented technology, the xvision system can project the patient`s anatomy, in real time, directly onto the surgeon`s retina, with surgical precision and outstanding depth perception. xvision will increase safety in surgery, reduce x-ray radiation, and facilitate minimally invasive procedures.

Shockwave Medical

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians` existing workflow.